Viagra Non-Prescription Switch Would Face High Bar For Safety
This article was originally published in The Tan Sheet
Executive Summary
Perhaps the greatest hurdle to an Rx-to-OTC switch of Pfizer's Viagra would be the broad expansion of existing safety concerns due to self-selection and off-label use issues in an over-the-counter setting, experts tell "The Tan Sheet."
You may also be interested in...
Pfizer Pulls Back On European Viagra Switch As Questions Linger
Pfizer withdraws its application to switch Viagra 50 mg from prescription to nonprescription status through the European Medicines Agency's centralized process, the company said Nov. 20
Pfizer Pulls Back On European Viagra Switch As Questions Linger
Pfizer withdraws its application to switch Viagra 50 mg from prescription to nonprescription status through the European Medicines Agency's centralized process, the company said Nov. 20
Pfizer Pulls Back On European Viagra Switch As Questions Linger
Pfizer withdraws its application to switch Viagra 50 mg from prescription to nonprescription status through the European Medicines Agency's centralized process, the company said Nov. 20